187 related articles for article (PubMed ID: 36135084)
1. Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma.
Holm MB; Verbeke CS
Curr Oncol; 2022 Sep; 29(9):6551-6563. PubMed ID: 36135084
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study.
Aaquist T; Fristrup CW; Hasselby JP; Hamilton-Dutoit S; Eld M; Pfeiffer P; Mortensen MB; Detlefsen S
Pathol Res Pract; 2024 Feb; 254():155077. PubMed ID: 38277754
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
Sahakyan MA; Verbeke CS; Tholfsen T; Ignjatovic D; Kleive D; Buanes T; Lassen K; Røsok BI; Labori KJ; Edwin B
Ann Surg Oncol; 2022 Jan; 29(1):366-375. PubMed ID: 34296358
[TBL] [Abstract][Full Text] [Related]
4. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
5. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
6. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
8. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
10. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
[TBL] [Abstract][Full Text] [Related]
11. Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma.
Leonhardt CS; Hinz U; Kaiser J; Hank T; Tjaden C; Bergmann F; Hackert T; Büchler MW; Strobel O
Eur J Surg Oncol; 2023 Jan; 49(1):113-121. PubMed ID: 35965217
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer Surgery: The New R-status Counts.
Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
[TBL] [Abstract][Full Text] [Related]
13. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
[TBL] [Abstract][Full Text] [Related]
14. [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].
Delpero JR; Turrini O
Bull Cancer; 2008 Dec; 95(12):1193-8. PubMed ID: 19091653
[TBL] [Abstract][Full Text] [Related]
15. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
16. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer.
Sugiura T; Uesaka K; Mihara K; Sasaki K; Kanemoto H; Mizuno T; Okamura Y
Surgery; 2013 Nov; 154(5):1078-86. PubMed ID: 23973112
[TBL] [Abstract][Full Text] [Related]
17. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer.
Yamamoto T; Uchida Y; Terajima H
Asian J Surg; 2019 Jan; 42(1):93-99. PubMed ID: 29249392
[TBL] [Abstract][Full Text] [Related]
19. Relevance of positive resection margins in ductal pancreatic adenocarcinoma and prognostic factors.
Ocaña J; Sanjuanbenito A; García A; Molina JM; Lisa E; Mendía E; Saavedra C; Lobo E
Cir Esp (Engl Ed); 2020 Feb; 98(2):85-91. PubMed ID: 31395275
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
